JAMES PANG: Open Payments
NPI 1790279446 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 58 payments from 15 companies in 2025. Trend: 2023 $1,343 · 2024 $1,200 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $328 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| Abbott Laboratories | 5 | $167 |
| Merck Sharp & Dohme LLC | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Medtronic, Inc. | 1 | $74 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
Products named: Wegovy, FREESTYLE LIBRE 3, Ozempic, VERQUVO, JARDIANCE, MINIMED 780G, BREZTRI, FARXIGA.
Industry payments across NJ — which companies pay providers there.
